HR Execs on the Move

Bayer

www.bayer.us

 
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Our products are helping to address some of today`s biggest challenges, including global population growth, an aging society and the need to make efficient – and, wherever possible, sustainable – use of natural resources. We are improving people`s quality of life by preventing, alleviating or curing diseases. We are helping to provide an ...
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion
  • www.bayer.us
  • 100 Bayer Boulevard
    Whippany, NJ USA 07981
  • Phone: +49 8624 043000

Executives

Name Title Contact Details
Rachel Koontz
VP R&D Allergy, Cough Cold, Pain & Cardio at Bayer Consumer Health Profile
David Caldwell
Head of Biologics Data Science, Biologics R&D, Bayer Crop Science Profile
David Townson
Executive, Oncology Research and Development : Immuno-Oncology, Cell Therapy Profile
Michelle Lamendola
Global R&D Director, Pipeline & Project Management Profile
Alexander Novak
Head of Laboratory – Process R&D Profile

Jobs

Director Human Resources

Bayer Berkeley, CA
YOUR TASKS AND RESPONSIBILITIES
The primary responsibilities of this role, as Director Human Resources, are to:
Pharma PS West Coast:

Provide leadership for global initiatives/processes and ensure
proper coordination between global and local;

Ensure the US perspective is clear at the global level and
partner in creating solutions;

Similar Companies

Eloxx Pharmaceuticals

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates that are designed to treat rare and ultra-rare premature stop codon diseases. Premature stop codons are point mutations that disrupt protein synthesis from messenger RNA. As a consequence, patients with premature stop codon diseases have reduced or eliminated protein production from the mutation bearing allele accounting for some of the most severe phenotypes in these genetic diseases. These premature stop codons have been identified in over 1,800 rare and ultra-rare diseases. Read-through therapeutic development is focused on extending mRNA half-life and increasing protein synthesis by enabling the cytoplasmic ribosome to read through premature stop codons to produce full-length proteins. Eloxx`s lead product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. ELX-02 is in the early stages of clinical development focusing on cystic fibrosis and cystinosis. ELX-02 is an investigational drug that has not been approved by any global regulatory body. Eloxx is headquartered in Waltham, MA, with R&D operations in Rehovot, Israel.

Global CINRG

Global CINRG is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Presutti Laboratories

Presutti Laboratories is a Rolling Meadows, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Akari Therapeutics

Akari Therapeutics is a clinical stage biopharmaceutical company focused on developing and commercializing treatments for rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5). Its lead drug, Covers...

Vascular Technology

Vascular Technology Incorporated is a Nashua, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.